Table 1 Clinical and tumour characteristics by treatment arm
No lymphadenectomy (130 patients) | Lymphadenectomy (138 patients) | |||
---|---|---|---|---|
n | % | n | % | |
Median age (25th–75th percentiles) | 52 (44–59) | 51 (43–60) | ||
FIGO Stage (at random, before pathologic staging) | ||||
I | 90 | 69.2 | 102 | 73.9 |
II | 39 | 30.0 | 33 | 23.9 |
Missing data | 1 | 0.8 | 3 | 2.2 |
Residual tumour | ||||
None | 126 | 96.9 | 133 | 96.4 |
⩽1 cm | 4 | 3.1 | 5 | 3.6 |
Tumour grade | ||||
1 | 20 | 15.4 | 30 | 21.7 |
2 | 41 | 31.5 | 29 | 21.0 |
3 | 65 | 50.0 | 72 | 52.2 |
Missing data | 4 | 3.1 | 7 | 5.1 |
Cell type | ||||
Serous | 43 | 33.1 | 61 | 44.2 |
Endometriod | 34 | 26.2 | 24 | 17.4 |
Mucinous | 22 | 16.9 | 14 | 10.1 |
Clear-cell | 19 | 14.6 | 16 | 11.6 |
Undifferentiated | 8 | 6.1 | 7 | 5.1 |
Other | 2 | 1.5 | 8 | 5.8 |
Missing data | 2 | 1.5 | 8 | 5.8 |